Press Release
EmpowerPharm Inc. Phase 2 Clinical Trial Finds CBD Promising for Treating Social Anxiety Disorder
BURLINGTON, ON - EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol...
SQDC reports net income of $104.1 million for fiscal 2023-2024
MONTRÉAL - For its fiscal year ended March 30, 2024, the Société québécoise du cannabis (SQDC) posted total sales of $662.1 million, compared with $601.9...
Canopy Growth Establishes US$250 Million At-The-Market Program to Facilitate Growth
SMITHS FALLS, ON - Canopy Growth Corporation has established an at-the-market equity program (the "ATM Program") that allows Canopy Growth to issue and sell up...
Grown Rogue AcquireS 44% of ABCO Garden State LLC
MEDFORD, Ore. - Grown Rogue International Inc., a craft cannabis company born from the amazing terroir of Oregon's Rogue Valley, announces it has received licensing...
Ascend Wellness Holdings Appoints Julie Francis to Board of Directors
NEW YORK - Ascend Wellness Holdings Inc., a vertically integrated multi-state cannabis operator focused on bettering lives through cannabis, appointed Julie Francis to its Board of...
STIIIZY APPOINTS TONY SHIN GENERAL COUNSEL
LOS ANGELES -- STIIIZY, a top-selling cannabis brand in the U.S., appointed Tony Shin General Counsel. Founded in 2017, STIIIZY employs more than 1,700 people. Shin is...
THC-SELTZER TRIPLE WINS GOLD MEDALS
MIAMI -- Triple, a THC-infused seltzer that hit the market in January 2024, has received multiple top medal awards.
The brand recently received accolades from both...
Canopy Growth Exercises Acreage Options
SMITHS FALLS, ON - Canopy Growth Corporation, a cannabis company dedicated to unleashing the power of cannabis to improve lives, exercised its option to acquire all...
Willow Industries Joins Cannabis Research Coalition
DENVER -- Willow Industries, a leader in cannabis decontamination technology and microbial control services, has partnered with the Cannabis Research Coalition (CRC). The collaboration is aimed to...
DEA Rescheduling Paves Way for Cannabis Processors in Pharma and Biotech
MIAMI -- The impending DEA rescheduling of marijuana to a Schedule III controlled substance presents a momentous opportunity for state-licensed cannabis processing businesses to...
